Abstract
The treatment of breast cancer is becoming more individualized and minimally invasive, which makes sentinel lymph node biopsy becoming the standard treatment for axillary in patients with early-stage breast cancer who are negative in clinical axillary lymph nodes. Tracers image sentinel lymph nodes or lymphatic vessels for the successful detection of sentinel lymph node biopsy. Tracers selection is also more diverse, such as nano carbon mixed suspension, methylene blue, radioisotope, indocyanine green, etc. Diffe-rent tracers and combined applications have their advantages and limitations. As for the selection of tracing methods, many factors need to be weighed. Key words: Breast neoplasms; Sentinel lymph node biopsy; Tracer
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
